Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19.
作者信息
Dadachova Ekaterina
机构信息
University of Saskatchewan Saskatoon, S7N 5E5, Saskatchewan, Canada E-mail:
出版信息
J Nucl Med. 2021 Jul 1;62(7):1020. doi: 10.2967/jnumed.120.261874. Epub 2021 May 7.
Abstract
摘要
相似文献
1
Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19.放射性标记抗体在新冠病毒成像与治疗中的潜在应用
J Nucl Med. 2021 Jul 1;62(7):1020. doi: 10.2967/jnumed.120.261874. Epub 2021 May 7.
2
Reply: Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19.回复：放射性标记抗体在新冠病毒成像与治疗中的潜在应用
J Nucl Med. 2021 Jul 1;62(7):1020-1021. doi: 10.2967/jnumed.121.261950. Epub 2021 Apr 23.
3
A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).一种新型的 SARS-CoV-2 刺突蛋白 1 抗原的快速检测方法，利用人血管紧张素转换酶 2（ACE2）。
Biosens Bioelectron. 2021 Jan 1;171:112715. doi: 10.1016/j.bios.2020.112715. Epub 2020 Oct 15.
4
Comment on "Imaging Findings of SARS-CoV-2 Infection in Pediatrics: A Systematic Review of Coronavirus Disease 2019 (COVID-19) in 850 Patients".评《儿童新型冠状病毒肺炎影像学表现：对850例2019冠状病毒病（COVID-19）的系统评价》
Acad Radiol. 2021 Oct;28(10):1480. doi: 10.1016/j.acra.2021.07.021. Epub 2021 Aug 9.
5
Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review.检测 SARS-CoV-2 病毒及 SARS-CoV-2 抗体以辅助 COVID-19 诊断的有效性：一项快速系统综述。
BMJ Evid Based Med. 2022 Feb;27(1):33-45. doi: 10.1136/bmjebm-2020-111511. Epub 2020 Oct 1.
6
Imaging in the aftermath of COVID-19: what to expect.新冠疫情后的影像学表现：预期情况
Eur Radiol. 2021 Jun;31(6):4390-4392. doi: 10.1007/s00330-020-07465-6. Epub 2020 Dec 28.
7
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.用于 COVID-19 预防和治疗的 SARS-CoV-2 中和抗体。
Annu Rev Med. 2022 Jan 27;73:1-16. doi: 10.1146/annurev-med-042420-113838. Epub 2021 Aug 24.
8
Cardiovascular Imaging in COVID-19.新型冠状病毒肺炎中的心血管成像
Arq Bras Cardiol. 2021 Aug;117(2):415. doi: 10.36660/abc.20201356.
9
Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.通过快速诊断免疫分析检测 COVID-19 患者的 SARS-CoV-2 特异性抗体。
Virol J. 2021 Mar 9;18(1):52. doi: 10.1186/s12985-021-01530-2.
10
Targeting Neuroinvasion by SARS-CoV-2: Emerging Trends in Drug and Antibody Delivery to Combat COVID-19.针对 SARS-CoV-2 的神经入侵：用于抗击 COVID-19 的药物和抗体递送至新兴趋势。
ACS Chem Neurosci. 2021 Jul 21;12(14):2555-2557. doi: 10.1021/acschemneuro.1c00372. Epub 2021 Jul 6.
本文引用的文献
1
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.预防性鼻腔内给予 TLR2/6 激动剂可减少 SARS-CoV-2 挑战雪貂模型的上呼吸道病毒脱落。
EBioMedicine. 2021 Jan;63:103153. doi: 10.1016/j.ebiom.2020.103153. Epub 2020 Dec 3.
2
Oncology-Inspired Treatment Options for COVID-19.肿瘤学启发的 COVID-19 治疗选择。
J Nucl Med. 2020 Dec;61(12):1720-1723. doi: 10.2967/jnumed.120.249748. Epub 2020 Jul 17.
3
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cells.比较用于清除 HIV 感染细胞的人源单克隆抗体对糖蛋白 41 的各种放射性有效载荷。
Nucl Med Biol. 2020 Mar-Apr;82-83:80-88. doi: 10.1016/j.nucmedbio.2020.02.009. Epub 2020 Feb 19.
4
Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals.抗逆转录病毒药物与放射免疫疗法联合使用可特异性杀死来自HIV感染者的受感染细胞。
Front Med (Lausanne). 2016 Sep 26;3:41. doi: 10.3389/fmed.2016.00041. eCollection 2016.
5
A fully human antibody to gp41 selectively eliminates HIV-infected cells that transmigrated across a model human blood brain barrier.一种针对gp41的全人源抗体可选择性清除穿越模拟人类血脑屏障迁移的HIV感染细胞。
AIDS. 2016 Feb 20;30(4):563-72. doi: 10.1097/QAD.0000000000000968.
6
Non-invasive nuclear imaging for localization of viral reservoirs.用于病毒储存库定位的非侵入性核成像
Nat Methods. 2015 May;12(5):399-400. doi: 10.1038/nmeth.3373.
7
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.全身免疫正电子发射断层扫描揭示了病毒血症猕猴和接受抗逆转录病毒治疗猕猴体内活跃的猴免疫缺陷病毒动态。
Nat Methods. 2015 May;12(5):427-32. doi: 10.1038/nmeth.3320. Epub 2015 Mar 9.
8
Targeting host cells harbouring viruses with radiolabeled antibodies.用放射性标记抗体靶向携带病毒的宿主细胞。
Expert Opin Biol Ther. 2007 May;7(5):595-7. doi: 10.1517/14712598.7.5.595.
9
Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins.通过针对病毒蛋白的放射性标记抗体对病毒感染细胞进行靶向杀伤。
PLoS Med. 2006 Nov;3(11):e427. doi: 10.1371/journal.pmed.0030427.
10
Effective use of optimized, high-dose (50 kGy) gamma irradiation for pathogen inactivation of human bone allografts.优化后的高剂量（50千戈瑞）伽马射线照射在人同种异体骨病原体灭活中的有效应用。
Biomaterials. 2005 May;26(14):2033-42. doi: 10.1016/j.biomaterials.2004.06.028.
Zotero 插件